NCT01240785View on ClinicalTrials.gov

Metformin Versus Insulin in Gestational Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2011

Study Completion Date

December 31, 2012

Conditions
Gestational Diabetes
Interventions
DRUG

metformin

metformin 1 g twice daily or maximum tolerated dose less than 2 g daily

DRUG

insulin

subcutaneous Neutral Protamine Hagedorn (NPH) insulin and/or rapid acting insulin analog adjusted according to plasma glucose values until delivery

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT01240785 - Metformin Versus Insulin in Gestational Diabetes | Biotech Hunter | Biotech Hunter